{"id":"NCT01535014","sponsor":"Materia Medica Holding","briefTitle":"Clinical Trial of Safety and Efficacy of Various Dosage Schedules for Dietressa Drug in Treatment of Obese Patients","officialTitle":"Multicentric Double-blind Placebo-controlled Randomized Parallel-group Clinical Trial of Safety and Efficacy of Various Dosage Schedules for Dietressa Drug in Treatment of Obese Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12-12","primaryCompletion":"2013-06","completion":"2013-06","firstPosted":"2012-02-17","resultsPosted":"2018-10-18","lastUpdate":"2018-11-28"},"enrollment":493,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Obesity"],"interventions":[{"type":"DRUG","name":"Dietressa","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Dietressa (2 tablets 3 times daily) for 24 weeks","type":"EXPERIMENTAL"},{"label":"Dietressa (1 tablet 6 times daily) for 24 weeks","type":"EXPERIMENTAL"},{"label":"Placebo (2 tablets 3 times daily)","type":"PLACEBO_COMPARATOR"},{"label":"Placebo (1 tablet 6 times daily)","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is:\n\n* To assess safety of Dietressa in the dose of 6 tablets daily within 24 weeks in treatment of obese patients.\n* To assess clinical efficacy of Dietressa in the dose of 6 tablets daily within 24 weeks of therapy in reducing body weight in obese patients.\n* To compare clinical efficacy of two dosage patterns for Dietressa (1 tablet 6 times daily and 2 tablets 3 times daily) within 24 weeks in treatment of obese patients.","primaryOutcome":{"measure":"Percentage of Subjects Who Lose at Least 5 Percent of Baseline Body Weight After 24 Weeks of Treatment Weeks of Treatment","timeFrame":"assessed after 24 weeks of treatment","effectByArm":[{"arm":"Dietressa 1","deltaMin":49,"sd":null},{"arm":"Dietressa 2","deltaMin":48,"sd":null},{"arm":"Placebo 3","deltaMin":33,"sd":null},{"arm":"Placebo 4","deltaMin":21,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.04"},{"comp":"OG001 vs OG003","p":"0.004"},{"comp":"OG000 vs OG001 vs OG002 vs OG003","p":"0.0007"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":17,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":410},"commonTop":["Increased anxiety on a scale HADS","Increased depression on a scale HADS","Subclinical anxiety","Subclinical depression","Increased appetite"]}}